# Phase 00 review record

Date: 2026-11-01. Status: **Documentation checks passed; ready for human review. Phase progression is not approved.** No clinical validation, dataset access, regulatory determination or phase progression is implied.

## Repository inspection and preservation
Inspected current directory, Git status, tracked/untracked inventory, existing AGENTS.md, README, ignore rules, architecture, roadmap and ADR index before editing. Branch: `main`, tracking `origin/main`; initial worktree clean. Existing repository contained only documentation/configuration, plus a tracked macOS `.DS_Store` metadata file; no application code, model, database or dataset existed. No Git initialization, remote changes, commits, pushes or user-data deletion performed.

All seven original tracked paths remain, including the existing `.DS_Store`; the new ignore rule prevents future untracked macOS metadata from being added but does not untrack that file. README, architecture, roadmap and ADR index were examined and expanded under the explicit Phase 00 request. Original AGENTS.md instructions and existing ignore rules were retained verbatim with additions. The attached approved five-tier/12-phase scope replaces the provisional component list and ten-step roadmap; no past implementation is assumed.

## Completed documentary tasks
- Requirement specification with 15 FR, 10 NFR and 10 SAFE IDs, priorities, acceptance criteria and intended phases.
- Five-tier architecture, component/data-flow/two-sequence/abstention diagrams, training/inference separation and failure boundaries.
- Thirteen canonical entities with explicit types, required/optional fields, units, lineage, revisions, knowledge-time and conceptual ER relationships.
- Proposed API contracts for health, auth, images, recognition/jobs, nutrition/confirmation, CGM/context ingestion, retrieval, forecasting, safety, restricted simulation and audits; JSON examples and common errors.
- Technology adoption/verification register, dataset acquisition gate, independent food/nutrition/glucose evaluation plans, and detailed graph/vector memory design.
- Safety/privacy specification and ten-entry qualitative risk register preserving existing boundaries; thresholds, protocol definitions and deployment settings remain unapproved.
- Development standards, all 12 roadmap phases with three-student ownership/durations, five ADRs, README/index, repository markers and development configuration.

These are specifications and plans. FR behavior, database schemas, endpoints, tests/CI, models and frontend are not implemented.

## File inventory
Modified existing files (6): `AGENTS.md`, `README.md`, `.gitignore`, `docs/architecture.md`, `docs/roadmap.md`, `docs/decisions/README.md`.

Created documentation (16): `docs/README.md`, `docs/requirements.md`, `docs/technology-stack.md`, `docs/data-model.md`, `docs/api-contracts.md`, `docs/datasets.md`, `docs/ml-research-plan.md`, `docs/memory-architecture.md`, `docs/safety-and-privacy.md`, `docs/development-standards.md`, this review, and five linked [ADRs](decisions/README.md).

Created `.editorconfig` and 16 `.gitkeep` markers: `apps/api`, `apps/web`, `packages/shared-contracts`, the five `services/*` domain directories, the four `ml/*` directories, `infrastructure/docker`, `infrastructure/migrations`, `tests`, and `.github/workflows`. No placeholder application code, manifests, dependencies or executable deployment/workflow settings added. Validation helpers ran from temporary local files outside the repository. Total: 33 new files and six modified files; the original `.DS_Store` is unchanged.

## Architecture decisions
ADR-001 preserves a modular monolith; ADR-002 distinguishes canonical PostgreSQL records from TimescaleDB layout and derived Neo4j/pgvector retrieval; ADR-003 requires baseline-led empirical model selection; ADR-004 separates forecasts, deterministic eligibility and conditional simulation; ADR-005 chooses web-first development. Their accepted directions originate in the user brief. No unrequested architecture or clinical-parameter choice is silently finalized.

## Requirements coverage and consistency review
FR-001–015 are mapped to future behavior and phase-level acceptance in requirements/roadmap, with API/data contracts covering their core interfaces. NFR-001–010 are addressed in standards, architecture and evaluation/governance plans. SAFE-001–010 recur in API output restrictions, model/memory boundaries and safety verification obligations. This is documentary coverage, not test evidence of implemented behavior.

Cross-document review checks five-tier naming, PostgreSQL authority/derived-index roles, unit/UUID/time conventions, human-confirmed meal revisions, knowledge-time filtering, uncertainty and no patient-facing dose outputs. Safety gates accompany each feature even though full safety/simulation consolidation is Phase 08. API job routes are scoped and used for both recognition and conditional simulation. Required supporting study/grant/consent/job/outbox types are explicitly deferred to their feature phases, not claimed present.

## Validation evidence
Executed local checks:

- `python3 /tmp/t1d_check_phase00.py` — **PASS**: 23 required files, 16 nonempty directory-marker paths, 21 Markdown documents, 70 resolving local links, five parseable JSON examples, 12 ordered phases, unique/contiguous FR=15/NFR=10/SAFE=10 IDs, all 13 entity sections, consistent tier names, and no application/data/model artifacts. Seven Mermaid blocks passed declaration/fence/delimiter checks. This temporary helper is not a committed/reusable project test suite.
- `git diff --check` — **PASS**, no whitespace errors in tracked changes. The helper also reads all new Markdown files and checks fence balance.
- `python3 -` with `git show HEAD:<path>` preservation assertions — **PASS**: original AGENTS.md and .gitignore are unchanged prefixes, and all seven original tracked files remain.
- `python3 -` using `git check-ignore --quiet --no-index <path>` — **PASS**, 20 ignore/non-ignore cases covering environment secrets/templates, Node/Next.js output, dataset/model/experiment/log/local-database artifacts, documentation, source, manifests and lockfiles. This tests naming behavior and does not create or inspect actual sensitive files.
- `git status --short` and `git diff --stat` — inspected; six tracked files modified, 33 new files, no tracked deletion. No staging, commits, pushes or remotes changed.
- `rg -n 'TODO|TBD|placeholder|clinical.*validat|dose|available_at|authoritative' docs README.md AGENTS.md` — manual consistency review completed for claims, source authority, temporal semantics and safety restrictions; no unfinished filler found.

Initial checker run flagged ER crow’s-foot `{` notation as an unmatched brace. This was a validator false positive; ER cardinality symbols were excluded from bracket balancing and the check reran successfully. Manual review also aligned CGM `source_event_ref` between data model and API.

**Not executed:** Mermaid parser/rendering (`command -v mmdc` found no installed renderer), external links/dataset/license/version verification, application unit/integration/safety/UI tests, CI, model evaluation or clinical validation. There is no runnable application or installed test toolchain to exercise. Seven diagrams were manually reviewed for obvious syntax and flow issues, but renderability is not proven. No dependencies/toolchains were installed.

## Unresolved decisions, risks and deferrals
- **Phase 01 preparation:** user review/approval, supported Python minor, package manager, exact lightweight dependency pins/licenses, initial identity/session/grant adapter and measurable CI scope. These do not authorize clinical policy or deployment changes.
- **Data governance:** intended study jurisdiction/audience, ethics/consent, lawful processing, official dataset releases/access/licenses/DUAs, permitted derivatives, acquisition ownership and retention. No actual dataset permissions verified locally.
- **Technology:** extension/edition combinations, macOS/Linux wheels, model/weight licenses, external-provider terms/costs, container/platform support, telemetry export and object-storage provider. All require evidence before adoption.
- **Clinical/research policy:** clinician-approved feature eligibility, CGM freshness/ranges/clock tolerances, uncertainty limits, episode definitions, parameter schemas, any FPU definition and any simulation protocol. No defaults supplied. Qualified clinician availability is a potential schedule blocker for clinical features.
- **Study design:** target metrics, minimum cohort/subgroup adequacy, calibration objectives, split/embargo windows, timing of available annotations and publication/disclosure rights. Small cohorts, missing knowledge-times and domain shift may limit conclusions.
- **Operations:** resource targets, upload/batch bounds, exact runtime/deployment settings, residency, key management, backup retention and deletion/training-influence handling remain proposals; no deployment authorization.
- **Documentation validation limit:** local link/JSON/structure checks do not prove clinical correctness, regulatory compliance, model validity or Mermaid renderability. Qualified review and later feature tests remain necessary.

## Phase 01 readiness and completion gate
The Phase 00 documentary scope can be ready for review once the final local checks pass. Human approval of the foundation and explicit authorization to proceed are still required; Phase 00 is not marked finally complete merely because files exist. No runtime tests apply to this documentation-only change, and no future tests are represented as passing.

Before Phase 01: review the scope/contracts/ADRs, confirm or amend outstanding near-term proposals, approve the next phase, and define a small health/configuration/error/auth-boundary slice with synthetic tests and exact dependency/version records. Do not acquire datasets, implement clinical features, configure deployment or start Phase 01 automatically.

## Subsequent authorization
On 2026-11-01 the user supplied the Phase 01 implementation request and explicitly approved the limited frontend/local-infrastructure addition after its timing difference was surfaced. The checks above remain the historical Phase 00 record; later code intentionally changes repository counts/scope. See [Phase 01 review](phase-01-review.md) for current implementation evidence.
